Gene content  |
|
|---|---|
| BCL3 (-- by HUGO) | |
| B-Cell CLL/Lymphoma 3 | |
| -- & Oncogene | |
| NCBI: 19q13.1-q13.2 Ensembl: 19q13.32 | |
| NONE | |
| Protein Domain/Family |
||||
|---|---|---|---|---|
| Source | ID | Domain | Name | Type |
| InterPro | IPR002110 | Ankyrin_rpt | Ankyrin | Repeat |
| Blocks | IPB002110 | Ankyrin repeat signature | Ankyrin repeat signature | |
| Gene Ontology |
||||
|---|---|---|---|---|
| Type | Term | Evidence | Source | Pub |
| Biological Process | nucleus | IEA | GOA | |
| Molecular Function | cytoplasmic sequestering of NF-kappaB | TAS | GOA | PubMed |
| regulation of progression through cell cycle | TAS | GOA | PubMed | |
| regulation of transcription, DNA-dependent | IEA | GOA | ||
| transcription | IEA | GOA | ||
| Disorder & Mutation |
||||
|---|---|---|---|---|
| Source | Disease | |||
| Genatlas | B cell lymphoma with translocation t(14;19)(q32;q13.1) | |||
| SWISS-PROT | Note=A chromosomal aberration involving BCL3 may be a cause of B-cell chronic lymphocytic leukemia (B-CLL). Translocation t(14;19)(q32;q13.1) with immunoglobulin gene regions | |||
| BCL3 cross reference |
||||||
|---|---|---|---|---|---|---|
|
||||||
